ACM
Aquilo Capital Management Portfolio holdings
AUM
$37.1M
This Quarter Return
+17.34%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$152M
AUM Growth
+$152M
(-11%)
Cap. Flow
-$41M
Cap. Flow
% of AUM
-26.92%
Top 10 Holdings %
Top 10 Hldgs %
98.27%
Holding
15
New
2
Increased
2
Reduced
7
Closed
1
Top Buys
| 1 |
Olema Pharmaceuticals
OLMA
|
$2.26M |
| 2 |
C4 Therapeutics
CCCC
|
$2.09M |
| 3 |
Kymera Therapeutics
KYMR
|
$1.15M |
| 4 |
Regenxbio
RGNX
|
$782K |
Top Sells
| 1 |
uniQure
QURE
|
$12.8M |
| 2 |
Merus
MRUS
|
$11.8M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$11M |
| 4 |
Arrowhead Research
ARWR
|
$5.71M |
| 5 |
argenx
ARGX
|
$3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Arrowhead Research
ARWR
$3.05B
| $30.6M | 16.96% | 858,474 -160,000 | -16% | -$5.71M |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $28.4M | 15.72% | 448,987 -173,842 | -28% | -$11M |
|
|
3
Merus
MRUS
$4.98B
| $20.4M | 11.31% | 775,109 -450,000 | -37% | -$11.8M |
|
|
4
Regenxbio
RGNX
$451M
| $17.4M | 9.64% | 870,114 +39,100 | +5% | +$782K |
|
5
Arvinas
ARVN
$568M
| $15.5M | 8.58% | 623,941 -5,000 | -0.8% | -$124K |
|
|
6
Kymera Therapeutics
KYMR
$2.95B
| $15M | 8.3% | 651,325 +50,000 | +8% | +$1.15M |
|
|
SLN
7
Silence Therapeutics
SLN
$227M
| $7.22M | 4% | 1,312,233 | – | – |
|
8
Genmab
GMAB
$15.3B
| $6.64M | 3.68% | 174,648 -68,200 | -28% | -$2.59M |
|
|
9
argenx
ARGX
$43.6B
| $6.36M | 3.52% | 16,315 -7,685 | -32% | -$3M |
|
|
10
Olema Pharmaceuticals
OLMA
$375M
| $2.26M | 1.25% | +250,000 | New | +$2.26M |
|
|
11
C4 Therapeutics
CCCC
$185M
| $2.09M | 1.16% | +760,657 | New | +$2.09M |
|
|
PVLA
12
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $547K | 0.3% | 3,303,190 -1,249,686 | -27% | -$207K |
|
13
iShares Russell 2000 ETF
IWM
$67B
| – | – | 0 | – | – |
|
14
Invesco QQQ Trust
QQQ
$364B
| – | – | 0 | – | – |
|
|
15
uniQure
QURE
$896M
| – | – | -637,526 | Closed | -$12.8M |
|